MOR103, a human monoclonal antibody to granulocyte–macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Erlangen
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
2015
|
| Online-Zugang: | Volltext Volltext Volltext |
| Beschreibung: | Aus: Annals of the Rheumatic Diseases 74.6 (2015): S. 1058-1064. <http://ard.bmj.com/content/74/6/1058> Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich. This publication is with permission of the rights owner freely accessible due to an Alliance licence or a national licence (funded by the DFG, German Research Foundation) respectively. |
| Beschreibung: | Online-Ressource |
| Format: | Langzeitarchivierung gewährleistet, LZA |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV044249312 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 170330s2015 gw |||| o||u| ||||||eng d | ||
| 015 | |a 17,O02 |2 dnb | ||
| 016 | 7 | |a 1124234365 |2 DE-101 | |
| 024 | 7 | |a urn:nbn:de:bvb:29-opus4-81490 |2 urn | |
| 035 | |a (OCoLC)1031440038 | ||
| 035 | |a (DE-599)DNB1124234365 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 044 | |a gw |c XA-DE-BY | ||
| 049 | |a DE-29 | ||
| 082 | 0 | |a 610 |2 23 | |
| 084 | |a 610 |2 sdnb | ||
| 100 | 1 | |a Behrens, Frank |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a MOR103, a human monoclonal antibody to granulocyte–macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis |b results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial |c Frank Behrens, Paul P. Tak, Mikkel Østergaard, Rumen Stoilov, Piotr Wiland, Thomas W. Huizinga, Vadym Y. Berenfus, Stoyanka Vladeva, Juergen Rech, Andrea Rubbert-Roth, Mariusz Korkosz, Dmitriy Rekalov, Igor A. Zupanets, Bo J. Ejbjerg, Jens Geiseler, Julia Fresenius, Roman P. Korolkiewicz, Arndt J. Schottelius, Harald Burkhardt |
| 264 | 1 | |a Erlangen |b Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) |c 2015 | |
| 300 | |a Online-Ressource | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Aus: Annals of the Rheumatic Diseases 74.6 (2015): S. 1058-1064. <http://ard.bmj.com/content/74/6/1058> | ||
| 500 | |a Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich. | ||
| 500 | |a This publication is with permission of the rights owner freely accessible due to an Alliance licence or a national licence (funded by the DFG, German Research Foundation) respectively. | ||
| 538 | |a Langzeitarchivierung gewährleistet, LZA | ||
| 700 | 1 | |a Tak, Paul P. |e Verfasser |4 aut | |
| 700 | 1 | |a Østergaard, Mikkel |e Verfasser |4 aut | |
| 700 | 1 | |a Stoilov, Rumen |e Verfasser |4 aut | |
| 700 | 1 | |a Wiland, Piotr |e Verfasser |4 aut | |
| 700 | 1 | |a Huizinga, Thomas W. |e Verfasser |4 aut | |
| 700 | 1 | |a Berenfus, Vadym Y. |e Verfasser |4 aut | |
| 700 | 1 | |a Vladeva, Stoyanka |e Verfasser |4 aut | |
| 700 | 1 | |a Rech, Juergen |e Verfasser |4 aut | |
| 700 | 1 | |a Rubbert-Roth, Andrea |e Verfasser |4 aut | |
| 700 | 1 | |a Korkosz, Mariusz |e Verfasser |4 aut | |
| 700 | 1 | |a Rekalov, Dmitriy |e Verfasser |4 aut | |
| 700 | 1 | |a Zupanets, Igor A. |e Verfasser |4 aut | |
| 700 | 1 | |a Ejbjerg, Bo J. |e Verfasser |4 aut | |
| 700 | 1 | |a Geiseler, Jens |e Verfasser |4 aut | |
| 700 | 1 | |a Fresenius, Julia |e Verfasser |4 aut | |
| 700 | 1 | |a Korolkiewicz, Roman P. |e Verfasser |4 aut | |
| 700 | 1 | |a Schottelius, Arndt J. |e Verfasser |4 aut | |
| 700 | 1 | |a Burkhardt, Harald |e Verfasser |4 aut | |
| 856 | 4 | 0 | |u https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-81490 |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u http://d-nb.info/1124234365/34 |x Langzeitarchivierung Nationalbibliothek |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://open.fau.de/handle/openfau/8149 |x Verlag |z kostenfrei |3 Volltext |
| 912 | |a ebook | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-029654427 | ||
Datensatz im Suchindex
| _version_ | 1804177416388608000 |
|---|---|
| any_adam_object | |
| author | Behrens, Frank Tak, Paul P. Østergaard, Mikkel Stoilov, Rumen Wiland, Piotr Huizinga, Thomas W. Berenfus, Vadym Y. Vladeva, Stoyanka Rech, Juergen Rubbert-Roth, Andrea Korkosz, Mariusz Rekalov, Dmitriy Zupanets, Igor A. Ejbjerg, Bo J. Geiseler, Jens Fresenius, Julia Korolkiewicz, Roman P. Schottelius, Arndt J. Burkhardt, Harald |
| author_facet | Behrens, Frank Tak, Paul P. Østergaard, Mikkel Stoilov, Rumen Wiland, Piotr Huizinga, Thomas W. Berenfus, Vadym Y. Vladeva, Stoyanka Rech, Juergen Rubbert-Roth, Andrea Korkosz, Mariusz Rekalov, Dmitriy Zupanets, Igor A. Ejbjerg, Bo J. Geiseler, Jens Fresenius, Julia Korolkiewicz, Roman P. Schottelius, Arndt J. Burkhardt, Harald |
| author_role | aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut |
| author_sort | Behrens, Frank |
| author_variant | f b fb p p t pp ppt m ø mø r s rs p w pw t w h tw twh v y b vy vyb s v sv j r jr a r r arr m k mk d r dr i a z ia iaz b j e bj bje j g jg j f jf r p k rp rpk a j s aj ajs h b hb |
| building | Verbundindex |
| bvnumber | BV044249312 |
| collection | ebook |
| ctrlnum | (OCoLC)1031440038 (DE-599)DNB1124234365 |
| dewey-full | 610 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 610 - Medicine and health |
| dewey-raw | 610 |
| dewey-search | 610 |
| dewey-sort | 3610 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03179nmm a2200625zc 4500</leader><controlfield tag="001">BV044249312</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">170330s2015 gw |||| o||u| ||||||eng d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">17,O02</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">1124234365</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">urn:nbn:de:bvb:29-opus4-81490</subfield><subfield code="2">urn</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1031440038</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DNB1124234365</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">XA-DE-BY</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-29</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">610</subfield><subfield code="2">sdnb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Behrens, Frank</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">MOR103, a human monoclonal antibody to granulocyte–macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis</subfield><subfield code="b">results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial</subfield><subfield code="c">Frank Behrens, Paul P. Tak, Mikkel Østergaard, Rumen Stoilov, Piotr Wiland, Thomas W. Huizinga, Vadym Y. Berenfus, Stoyanka Vladeva, Juergen Rech, Andrea Rubbert-Roth, Mariusz Korkosz, Dmitriy Rekalov, Igor A. Zupanets, Bo J. Ejbjerg, Jens Geiseler, Julia Fresenius, Roman P. Korolkiewicz, Arndt J. Schottelius, Harald Burkhardt</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Erlangen</subfield><subfield code="b">Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)</subfield><subfield code="c">2015</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Aus: Annals of the Rheumatic Diseases 74.6 (2015): S. 1058-1064. <http://ard.bmj.com/content/74/6/1058></subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich.</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">This publication is with permission of the rights owner freely accessible due to an Alliance licence or a national licence (funded by the DFG, German Research Foundation) respectively.</subfield></datafield><datafield tag="538" ind1=" " ind2=" "><subfield code="a">Langzeitarchivierung gewährleistet, LZA</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tak, Paul P.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Østergaard, Mikkel</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Stoilov, Rumen</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wiland, Piotr</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Huizinga, Thomas W.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Berenfus, Vadym Y.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Vladeva, Stoyanka</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rech, Juergen</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rubbert-Roth, Andrea</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Korkosz, Mariusz</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rekalov, Dmitriy</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zupanets, Igor A.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ejbjerg, Bo J.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Geiseler, Jens</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fresenius, Julia</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Korolkiewicz, Roman P.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schottelius, Arndt J.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Burkhardt, Harald</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-81490</subfield><subfield code="x">Resolving-System</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://d-nb.info/1124234365/34</subfield><subfield code="x">Langzeitarchivierung Nationalbibliothek</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://open.fau.de/handle/openfau/8149</subfield><subfield code="x">Verlag</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ebook</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029654427</subfield></datafield></record></collection> |
| id | DE-604.BV044249312 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:47:44Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029654427 |
| oclc_num | 1031440038 |
| open_access_boolean | 1 |
| owner | DE-29 |
| owner_facet | DE-29 |
| physical | Online-Ressource |
| psigel | ebook |
| publishDate | 2015 |
| publishDateSearch | 2015 |
| publishDateSort | 2015 |
| publisher | Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) |
| record_format | marc |
| spelling | Behrens, Frank Verfasser aut MOR103, a human monoclonal antibody to granulocyte–macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial Frank Behrens, Paul P. Tak, Mikkel Østergaard, Rumen Stoilov, Piotr Wiland, Thomas W. Huizinga, Vadym Y. Berenfus, Stoyanka Vladeva, Juergen Rech, Andrea Rubbert-Roth, Mariusz Korkosz, Dmitriy Rekalov, Igor A. Zupanets, Bo J. Ejbjerg, Jens Geiseler, Julia Fresenius, Roman P. Korolkiewicz, Arndt J. Schottelius, Harald Burkhardt Erlangen Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) 2015 Online-Ressource txt rdacontent c rdamedia cr rdacarrier Aus: Annals of the Rheumatic Diseases 74.6 (2015): S. 1058-1064. <http://ard.bmj.com/content/74/6/1058> Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich. This publication is with permission of the rights owner freely accessible due to an Alliance licence or a national licence (funded by the DFG, German Research Foundation) respectively. Langzeitarchivierung gewährleistet, LZA Tak, Paul P. Verfasser aut Østergaard, Mikkel Verfasser aut Stoilov, Rumen Verfasser aut Wiland, Piotr Verfasser aut Huizinga, Thomas W. Verfasser aut Berenfus, Vadym Y. Verfasser aut Vladeva, Stoyanka Verfasser aut Rech, Juergen Verfasser aut Rubbert-Roth, Andrea Verfasser aut Korkosz, Mariusz Verfasser aut Rekalov, Dmitriy Verfasser aut Zupanets, Igor A. Verfasser aut Ejbjerg, Bo J. Verfasser aut Geiseler, Jens Verfasser aut Fresenius, Julia Verfasser aut Korolkiewicz, Roman P. Verfasser aut Schottelius, Arndt J. Verfasser aut Burkhardt, Harald Verfasser aut https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-81490 Resolving-System kostenfrei Volltext http://d-nb.info/1124234365/34 Langzeitarchivierung Nationalbibliothek kostenfrei Volltext https://open.fau.de/handle/openfau/8149 Verlag kostenfrei Volltext |
| spellingShingle | Behrens, Frank Tak, Paul P. Østergaard, Mikkel Stoilov, Rumen Wiland, Piotr Huizinga, Thomas W. Berenfus, Vadym Y. Vladeva, Stoyanka Rech, Juergen Rubbert-Roth, Andrea Korkosz, Mariusz Rekalov, Dmitriy Zupanets, Igor A. Ejbjerg, Bo J. Geiseler, Jens Fresenius, Julia Korolkiewicz, Roman P. Schottelius, Arndt J. Burkhardt, Harald MOR103, a human monoclonal antibody to granulocyte–macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial |
| title | MOR103, a human monoclonal antibody to granulocyte–macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial |
| title_auth | MOR103, a human monoclonal antibody to granulocyte–macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial |
| title_exact_search | MOR103, a human monoclonal antibody to granulocyte–macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial |
| title_full | MOR103, a human monoclonal antibody to granulocyte–macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial Frank Behrens, Paul P. Tak, Mikkel Østergaard, Rumen Stoilov, Piotr Wiland, Thomas W. Huizinga, Vadym Y. Berenfus, Stoyanka Vladeva, Juergen Rech, Andrea Rubbert-Roth, Mariusz Korkosz, Dmitriy Rekalov, Igor A. Zupanets, Bo J. Ejbjerg, Jens Geiseler, Julia Fresenius, Roman P. Korolkiewicz, Arndt J. Schottelius, Harald Burkhardt |
| title_fullStr | MOR103, a human monoclonal antibody to granulocyte–macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial Frank Behrens, Paul P. Tak, Mikkel Østergaard, Rumen Stoilov, Piotr Wiland, Thomas W. Huizinga, Vadym Y. Berenfus, Stoyanka Vladeva, Juergen Rech, Andrea Rubbert-Roth, Mariusz Korkosz, Dmitriy Rekalov, Igor A. Zupanets, Bo J. Ejbjerg, Jens Geiseler, Julia Fresenius, Roman P. Korolkiewicz, Arndt J. Schottelius, Harald Burkhardt |
| title_full_unstemmed | MOR103, a human monoclonal antibody to granulocyte–macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial Frank Behrens, Paul P. Tak, Mikkel Østergaard, Rumen Stoilov, Piotr Wiland, Thomas W. Huizinga, Vadym Y. Berenfus, Stoyanka Vladeva, Juergen Rech, Andrea Rubbert-Roth, Mariusz Korkosz, Dmitriy Rekalov, Igor A. Zupanets, Bo J. Ejbjerg, Jens Geiseler, Julia Fresenius, Roman P. Korolkiewicz, Arndt J. Schottelius, Harald Burkhardt |
| title_short | MOR103, a human monoclonal antibody to granulocyte–macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis |
| title_sort | mor103 a human monoclonal antibody to granulocyte macrophage colony stimulating factor in the treatment of patients with moderate rheumatoid arthritis results of a phase ib iia randomised double blind placebo controlled dose escalation trial |
| title_sub | results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial |
| url | https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-81490 http://d-nb.info/1124234365/34 https://open.fau.de/handle/openfau/8149 |
| work_keys_str_mv | AT behrensfrank mor103ahumanmonoclonalantibodytogranulocytemacrophagecolonystimulatingfactorinthetreatmentofpatientswithmoderaterheumatoidarthritisresultsofaphaseibiiarandomiseddoubleblindplacebocontrolleddoseescalationtrial AT takpaulp mor103ahumanmonoclonalantibodytogranulocytemacrophagecolonystimulatingfactorinthetreatmentofpatientswithmoderaterheumatoidarthritisresultsofaphaseibiiarandomiseddoubleblindplacebocontrolleddoseescalationtrial AT østergaardmikkel mor103ahumanmonoclonalantibodytogranulocytemacrophagecolonystimulatingfactorinthetreatmentofpatientswithmoderaterheumatoidarthritisresultsofaphaseibiiarandomiseddoubleblindplacebocontrolleddoseescalationtrial AT stoilovrumen mor103ahumanmonoclonalantibodytogranulocytemacrophagecolonystimulatingfactorinthetreatmentofpatientswithmoderaterheumatoidarthritisresultsofaphaseibiiarandomiseddoubleblindplacebocontrolleddoseescalationtrial AT wilandpiotr mor103ahumanmonoclonalantibodytogranulocytemacrophagecolonystimulatingfactorinthetreatmentofpatientswithmoderaterheumatoidarthritisresultsofaphaseibiiarandomiseddoubleblindplacebocontrolleddoseescalationtrial AT huizingathomasw mor103ahumanmonoclonalantibodytogranulocytemacrophagecolonystimulatingfactorinthetreatmentofpatientswithmoderaterheumatoidarthritisresultsofaphaseibiiarandomiseddoubleblindplacebocontrolleddoseescalationtrial AT berenfusvadymy mor103ahumanmonoclonalantibodytogranulocytemacrophagecolonystimulatingfactorinthetreatmentofpatientswithmoderaterheumatoidarthritisresultsofaphaseibiiarandomiseddoubleblindplacebocontrolleddoseescalationtrial AT vladevastoyanka mor103ahumanmonoclonalantibodytogranulocytemacrophagecolonystimulatingfactorinthetreatmentofpatientswithmoderaterheumatoidarthritisresultsofaphaseibiiarandomiseddoubleblindplacebocontrolleddoseescalationtrial AT rechjuergen mor103ahumanmonoclonalantibodytogranulocytemacrophagecolonystimulatingfactorinthetreatmentofpatientswithmoderaterheumatoidarthritisresultsofaphaseibiiarandomiseddoubleblindplacebocontrolleddoseescalationtrial AT rubbertrothandrea mor103ahumanmonoclonalantibodytogranulocytemacrophagecolonystimulatingfactorinthetreatmentofpatientswithmoderaterheumatoidarthritisresultsofaphaseibiiarandomiseddoubleblindplacebocontrolleddoseescalationtrial AT korkoszmariusz mor103ahumanmonoclonalantibodytogranulocytemacrophagecolonystimulatingfactorinthetreatmentofpatientswithmoderaterheumatoidarthritisresultsofaphaseibiiarandomiseddoubleblindplacebocontrolleddoseescalationtrial AT rekalovdmitriy mor103ahumanmonoclonalantibodytogranulocytemacrophagecolonystimulatingfactorinthetreatmentofpatientswithmoderaterheumatoidarthritisresultsofaphaseibiiarandomiseddoubleblindplacebocontrolleddoseescalationtrial AT zupanetsigora mor103ahumanmonoclonalantibodytogranulocytemacrophagecolonystimulatingfactorinthetreatmentofpatientswithmoderaterheumatoidarthritisresultsofaphaseibiiarandomiseddoubleblindplacebocontrolleddoseescalationtrial AT ejbjergboj mor103ahumanmonoclonalantibodytogranulocytemacrophagecolonystimulatingfactorinthetreatmentofpatientswithmoderaterheumatoidarthritisresultsofaphaseibiiarandomiseddoubleblindplacebocontrolleddoseescalationtrial AT geiselerjens mor103ahumanmonoclonalantibodytogranulocytemacrophagecolonystimulatingfactorinthetreatmentofpatientswithmoderaterheumatoidarthritisresultsofaphaseibiiarandomiseddoubleblindplacebocontrolleddoseescalationtrial AT freseniusjulia mor103ahumanmonoclonalantibodytogranulocytemacrophagecolonystimulatingfactorinthetreatmentofpatientswithmoderaterheumatoidarthritisresultsofaphaseibiiarandomiseddoubleblindplacebocontrolleddoseescalationtrial AT korolkiewiczromanp mor103ahumanmonoclonalantibodytogranulocytemacrophagecolonystimulatingfactorinthetreatmentofpatientswithmoderaterheumatoidarthritisresultsofaphaseibiiarandomiseddoubleblindplacebocontrolleddoseescalationtrial AT schotteliusarndtj mor103ahumanmonoclonalantibodytogranulocytemacrophagecolonystimulatingfactorinthetreatmentofpatientswithmoderaterheumatoidarthritisresultsofaphaseibiiarandomiseddoubleblindplacebocontrolleddoseescalationtrial AT burkhardtharald mor103ahumanmonoclonalantibodytogranulocytemacrophagecolonystimulatingfactorinthetreatmentofpatientswithmoderaterheumatoidarthritisresultsofaphaseibiiarandomiseddoubleblindplacebocontrolleddoseescalationtrial |